| 产品名称 | Bupropion hydrochloride - BW 322U | BVF 033 | Amfebutamone |
| 产品货号 | Axon 1451 CAS [31677-93-7] MF C13H18ClNO.HClMW 276.20 Purity: 99% Soluble in water and DMSO Description A dopamine and noradrenaline reuptake inhibitor and nicotinic acetylcholine receptor antagonist indicated for the treatment of major depressive disorder (MDD) and for the prevention of seasonal major depressive episodes in patients with seasonal affective disorder (SAD) References Certificates Categories Extra info RA Sweet et al. Pharmacokinetics of single-and multiple dose bupropion in elderly patients with depression. J Clin Pharmacol 1995, 35(9), 876-884. RT Segraves et al. Evaluation of sexual functioning depressed outpatients: A double-blind comparison of sustained-release bupropion and sertraline treatment. J Clin Psychopharmacol 2000, 20(2), 122-128. Certificate of Analysis Material Safety Data Sheet CNS DRI Unclassified DRI and NRI; nicotinic acetylcholine receptor antagonist Chemical name 1-(3-Chlorophenyl)-2-[(1,1-dimethylethyl)amino]-1-propanone hydrochloride Parent CAS No. [34911-55-2] Order Size Unit Price Stock 50 mg €85.00 In Stock |
| 产品价格 | 现货询价，电话：010-67529703 |
| 产品规格 | |
| 产品品牌 | axonmedchem |
| 产品概述 | |
| 产品详情 |
Bupropion hydrochloride - BW 322U | BVF 033 | AmfebutamoneAxon 1451 CAS [31677-93-7] MF C13H18ClNO.HCl
Description
A dopamine and noradrenaline reuptake inhibitor and nicotinic acetylcholine receptor antagonist indicated for the treatment of major depressive disorder (MDD) and for the prevention of seasonal major depressive episodes in patients with seasonal affective disorder (SAD)
DRI and NRI; nicotinic acetylcholine receptor antagonist
Chemical name1-(3-Chlorophenyl)-2-[(1,1-dimethylethyl)amino]-1-propanone hydrochloride Parent CAS No.[34911-55-2] |
| 产品资料 |
